83 Results for "

TP receptor

" in MedChemExpress (MCE) Product Catalog:
Products (83)

83 Results for "TP receptor" in MCE Product Catalog:

16
16 Publications Verification
Cat. No.: HY-108566
CAS No.: 56985-40-1
Purity:  ≥98.0%
Synonyms: 9,11-Methanoepoxy PGH2
Research Areas:  

Cardiovascular Disease

U-46619 (9,11-Methanoepoxy PGH2) is a stable analogue of Thromboxane A2 (HY-113350) (TXA2) and acts as a potent TXA2 (TP) agonist. U-46619 also is a RhoA agonist. U-46619 stimulates the activation of RhoA through TXA2 receptor activation .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-50901
CAS No.: 402473-54-5
Synonyms: AE 3-208
Research Areas:  

Endocrinology Cancer

ONO-AE3-208 is a selective and orally active EP4 receptor antagonist with a Ki of 1.3 nM. ONO-AE3-208 shows less potently affects EP3, FP, and TP receptors (Ki of 30 nM, 790 nM, and 2400 nM, respectively). ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-12963
CAS No.: 1341200-45-0
Purity:  99.84%
Synonyms: TP-0903
Target:  

TAM Receptor Apoptosis

Research Areas:  

Cancer

Dubermatinib (TP-0903) is a potent and selective Axl receptor tyrosine kinase inhibitor with an IC50 value of 27 nM.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-16963
CAS No.: 439288-66-1
GW627368 (GW627368X) is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor with additional human TP receptor affinity, with pKi values of 7.0 and 6.8 for human prostanoid EP4 and TP receptors respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-B0774
CAS No.: 112665-43-7
Synonyms: AA 2414
Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108563
CAS No.: 146033-02-5
Research Areas:  

Neurological Disease

SC 51089 is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 exhibits neuroprotective activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108563A
CAS No.: 146033-03-6
Purity:  98.64%
Research Areas:  

Neurological Disease

SC 51089 free base is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 free base exhibits neuroprotective activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16991
CAS No.: 165538-40-9
Synonyms: S-18886
Terutroban (S-18886) is a selective and orally active thromboxane-prostaglandin (TP) receptor antagonist with an IC50 of 16.4 nM. Terutroban inhibits TXA2 and prostaglandin endoperoxide receptors. Terutroban is a potent antithrombotic agent and possesses anti-atherosclerotic and anti-vasoconstrictor properties .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16991A
CAS No.: 609340-89-8
Synonyms: S-18886 sodium
Terutroban (S-18886) sodium is a selective and orally active thromboxane-prostaglandin (TP) receptor antagonist with an IC50 of 16.4 nM. Terutroban sodium inhibits TXA2 and prostaglandin endoperoxide receptors. Terutroban sodium is a potent antithrombotic agent and possesses anti-atherosclerotic and anti-vasoconstrictor properties .
loading...
    loading...
Cat. No.: HY-147316
CAS No.: 2574474-81-8
Purity:  99.69%
Target:  

STAT TNK1

Research Areas:  

Cancer

TP-5801 is an orally active TNK1 (non-receptor tyrosine kinase) inhibitor (IC50=1.40 nM), and shows anti-tumor activity .
loading...
    loading...
Cat. No.: HY-105042
CAS No.: 129954-34-3
Synonyms: Selanc; TP-7
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Selank (Selanc; TP-7) is a GABAA receptor modulator with anxiolytic activity. Selank allosterically modulates the specific binding of GABA to GABAA receptors and alters the affinity of endogenous ligands for these receptors. Selank reduces elevated anxiety levels, attenuates stress-induced exacerbation of anxiety, and produces a synergistic anxiolytic effect with diazepam. Selank can be used in the research of anxiety disorders .
loading...
    loading...
Cat. No.: HY-108972
CAS No.: 98672-91-4
Purity:  ≥99.0%
Research Areas:  

Metabolic Disease

SQ 29548 is a selective thromboxane-prostanoid (TP) receptor antagonist .
loading...
    loading...
Cat. No.: HY-50175
CAS No.: 571170-77-9
Synonyms: MK-0524
Laropiprant is a potent and selective DP receptor antagonist with Ki values of 0.57 nM and 2.95 nM for DP receptor and TP Receptor, respectively .
loading...
    loading...
Cat. No.: HY-150270A
CAS No.: 1239578-80-3
Purity:  99.62%
NP-1815-PX sodium is an orally active dual inhibitor of P2X4 and prostaglandin TP receptors, with an IC50 of 0.26 μM against human P2X4 receptors. NP-1815-PX sodium specifically inhibits ATP-mediated prostaglandin production, TP receptor-induced calcium elevation, and the canonical/non-canonical NLRP3 inflammasome signaling pathway. NP-1815-PX sodium selectively blocks smooth muscle contractions induced by ATP, U46619 (HY-108566) and prostaglandin F2α. NP-1815-PX sodium not only produces anti-allodynic effects in vivo, but also significantly alleviates symptoms of DNBS (HY-W324435)-induced colitis (such as weight loss and tissue damage). NP-1815-PX sodium exerts anti-inflammatory effects by downregulating IL-1β levels and Caspase-1 activity. NP-1815-PX sodium is used in studies related to asthma and inflammatory bowel disease (colitis) .
loading...
    loading...
Cat. No.: HY-105042A
Purity:  99.90%
Synonyms: Selanc diacetate; TP-7 diacetate
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Selank diacetate (Selanc diacetate; TP-7 diacetate) is a GABAA receptor modulator with anxiolytic activity. Selank diacetate allosterically modulates the specific binding of GABA to GABAA receptors and alters the affinity of endogenous ligands for these receptors. Selank diacetate reduces elevated anxiety levels, attenuates stress-induced exacerbation of anxiety, and produces a synergistic anxiolytic effect with diazepam. Selank diacetate can be used in the research of anxiety disorders .
loading...
    loading...
Cat. No.: HY-129851
CAS No.: 2055599-51-2
Purity:  98.58%
Research Areas:  

Cardiovascular Disease

NTP42 is a thromboxane A2 (TXA2) receptor antagonist with an IC50 of 3.278 nM for antagonizing T prostanoid receptor (TP)- mediated [Ca 2+] mobilization following stimulation of cells with the alternative TP agonist U46619 . NTP42 can be used for the treatment of pulmonary arterial hypertension (PAH) .
loading...
    loading...
Cat. No.: HY-113209
CAS No.: 27415-26-5
Purity:  ≥99.0%
Synonyms: 8-iso-PGF2α
8-Isoprostaglandin F2α is an isoprostane produced by the non-enzymatic peroxidation of arachidonic acid in membrane phospholipids. 8-Isoprostaglandin F2α is present in human plasma in two distinct forms - esterified in phospholipids and as the free acid. 8-Isoprostaglandin F2α is a weak TP receptor agonist in vascular smooth muscle.
loading...
    loading...
Cat. No.: HY-50848
CAS No.: 118675-50-6
Research Areas:  

Cardiovascular Disease

BW A868C, a hydantoin compound, is a BW245C structural analogue. BW A868C is a selective and potent competitive prostaglandin D2 (PGD2) antagonist. BW A868C has no effect on other prostaglandin receptors (IP, EP1, EP2, TP and FP) .
loading...
    loading...
Cat. No.: HY-176990
CAS No.: 165537-72-4
TP receptor antagonist-3 (compound 51280) is a potent thromboxane A2 prostanoid (TP) receptor with an IC50 of 15.7 nM against Human TP. TP receptor antagonist-3 can be used for alzheimer's disease, cardiovascular and respiratory diseases, and cancer research .
loading...
    loading...
Cat. No.: HY-107835
CAS No.: 69770-45-2
Purity:  95.20%
Synonyms: FCR 2769
Flumethrin (FCR 2769) is a pyrethroid insecticide and acaricide . Flumethrin targets voltage-gated sodium channels and estrogen receptor α (ERα). Flumethrin induces cytotoxicity, apoptosis, genotoxicity and DNA damage in breast cancer cells by regulating the expression of BCL2, BAX, TP53 and P21 genes. Flumethrin is applicable to relevant studies on ectoparasite infections (tick and flea burdens) in dogs and cats, as well as breast cancer .
loading...
    loading...